Elaboration and evaluation of alginate foam scaffolds for soft tissue engineering

Int J Pharm. 2017 May 30;524(1-2):433-442. doi: 10.1016/j.ijpharm.2017.02.060. Epub 2017 Mar 6.

Abstract

Controlling microarchitecture in polymer scaffolds is a priority in material design for soft tissue applications. This paper reports for the first time the elaboration of alginate foam-based scaffolds for mesenchymal stem cell (MSC) delivery and a comparative study of various surfactants on the final device performance. The use of surfactants permitted to obtain highly interconnected porous scaffolds with tunable pore size on surface and in cross-section. Their mechanical properties in compression appeared to be adapted to soft tissue engineering. Scaffold structures could sustain MSC proliferation over 14 days. Paracrine activity of scaffold-seeded MSCs varied with the scaffold structure and growth factors release was globally improved in comparison with control alginate scaffolds. Our results provide evidence that exploiting different surfactant types for alginate foam preparation could be an original method to obtain biocompatible scaffolds with tunable architecture for soft tissue engineering.

Keywords: Alginate; Foam-based scaffolds; Mesenchymal stem cells; Soft tissue engineering; Surfactants.

MeSH terms

  • Alginates / chemistry*
  • Biocompatible Materials*
  • Glucuronic Acid / chemistry
  • Hexuronic Acids / chemistry
  • Humans
  • Mesenchymal Stem Cells / cytology*
  • Porosity
  • Tissue Engineering*
  • Tissue Scaffolds*

Substances

  • Alginates
  • Biocompatible Materials
  • Hexuronic Acids
  • Glucuronic Acid